CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −458 | $139.20 | $64K | 70,791 |
| 2025-07-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −297 | $139.95 | $42K | 70,494 |
| 2025-07-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −495 | $141.28 | $70K | 71,249 |
| 2025-07-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −920 | $139.58 | $128K | 70,494 |
| 2025-07-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,250 | 71,744 | ||
| 2025-07-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −1,250 | 1,250 | ||
| 2025-07-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −602 | $139.29 | $84K | 71,414 |
| 2025-07-21 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,622 | $139.29 | $226K | 175,492 |
| 2025-07-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −464 | $139.29 | $65K | 204,158 |
| 2025-07-21 | Sheena Jonathan Director | Sale 10b5-1 | −93 | $139.29 | $13K | 245,801 |
| 2025-07-21 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −291 | $139.29 | $41K | 128,265 |
| 2025-07-21 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −339 | $139.29 | $47K | 153,460 |
| 2025-07-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,522 | 72,016 | ||
| 2025-07-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −1,522 | 3,044 | ||
| 2025-07-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +3,386 | 177,114 | ||
| 2025-07-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Restricted Stock Unit 10b5-1 | −3,386 | 6,772 | ||
| 2025-07-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +856 | 204,622 | ||
| 2025-07-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −856 | 1,712 | ||
| 2025-07-20 | Sheena Jonathan Director | Option exercise 10b5-1 | +190 | 245,894 | ||
| 2025-07-20 | Sheena Jonathan Director | Option exercise · Restricted Stock Unit 10b5-1 | −190 | 381 |
Page 42 of 55 · 1,093 trades